Receptor-type tyrosine-protein phosphatase F
Homo sapiens
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein monomer Monomer Protein × 1 PDB declaration: monomeric(1) Consistent with protein copy count | Chain A; UniProt 513–706 | Not recorded | CL CHLORIDE ION × 1 | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION;pH 7;277 K;1.8 M Ammonium citrate tribasic pH 7.0 | Resolution 1.55 Å R-free 0.193 |
| 2 | Protein monomer Monomer Protein × 1 PDB declaration: monomeric(1) Consistent with protein copy count | Chain B; UniProt 513–706 | Not recorded | CL CHLORIDE ION × 2 | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION;pH 7;277 K;1.8 M Ammonium citrate tribasic pH 7.0 | Resolution 1.55 Å R-free 0.193 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 6TPU | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1LAR CRYSTAL STRUCTURE OF THE TANDEM PHOSPHATASE DOMAINS OF RPTP LAR Deposited 1999-04-20 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1323–1897(575 aa)
Fragment:PHOSPHATASE
|
Mutation:P1307M | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;pH 8.0
|
Resolution 2.00 Å R-free 0.274 |
| 1LAR CRYSTAL STRUCTURE OF THE TANDEM PHOSPHATASE DOMAINS OF RPTP LAR Deposited 1999-04-20 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
1323–1897(575 aa)
Fragment:PHOSPHATASE
|
Mutation:P1307M | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;pH 8.0
|
Resolution 2.00 Å R-free 0.274 |
| 2DJU Solution structures of the fn3 domain of human receptor-type tyrosine-protein phosphatase F Deposited 2006-04-05 | Different construct Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
309–401(93 aa)
Fragment:Fibronectin type III domain
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 120mM;Pressure ambient
NMR sample composition
1mM fn3 domain U-15N, 13C; 20mM d-Tris HCl; 100mM NaCl; 1mM d-DTT; 0.02% NaN3; 90% H2O, 10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 2DN7 Solution structures of the 6th fn3 domain of human receptor-type tyrosine-protein phosphatase F Deposited 2006-04-25 | Different construct Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
811–904(94 aa)
Fragment:Fibronectin type III domain
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 7;296 K;Ionic strength (raw mmCIF value) 120mM;Pressure ambient
NMR sample composition
1mM fn3 domain U-15N,13C; 20mM d-Tris HCl; 100mM NaCl; 1mM d-DTT; 0.02% NaN3; 10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 2EDY Solution structures of the fn3 domain of human receptor-type tyrosine-protein phosphatase F Deposited 2007-02-15 | Different construct Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
905–1000(96 aa)
Fragment:Fibronectin type III domain
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 120mM;Pressure ambient
NMR sample composition
1mM fn3 domain U-15N, 13C; 20mM d-Tris HCl; 100mM NaCl; 1mM d-DTT; 0.02% NaN3; 90% H2O, 10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 2YD5 Crystal structure of the N-terminal Ig1-2 module of Human Receptor Protein Tyrosine Phosphatase LAR Deposited 2011-03-17 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
29–231(203 aa)
Fragment:IG1-2, RESIDUES 29-231
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.6;0.1 M SODIUM ACETATE TRIHYDRATE, 20% ISOPROPANOL, 20% (W/V) PEG 4000, 0.25 MM HEPARIN DP10, PH 5.6 .
|
Resolution 2.20 Å R-free 0.233 |
| 2YD8 Crystal structure of the N-terminal Ig1-2 module of Human Receptor Protein Tyrosine Phosphatase LAR in complex with sucrose octasulphate Deposited 2011-03-18 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
29–231(203 aa)
Fragment:IG1-2, RESIDUES 29-231
|
Not recorded | YYJ 1,3,4,6-tetra-O-sulfo-beta-D-fructofuranose × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6;0.1 M MES, 30% PEG 6000, PH 6.0 .
|
Resolution 2.05 Å R-free 0.227 |
| 4N5U Crystal structure of the 4th FN3 domain of human Protein Tyrosine phosphatase, receptor type F [PSI-NYSGRC-006240] Deposited 2013-10-10 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
601–705(105 aa)
Fragment:Fibronectin type-III 4 domain, residues 601-705
|
Not recorded | SO4 SULFATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 10.5;298 K;Protein (20 mM Hepes, pH 7.5, 150 mM NaCl, 5% glycerol, Reservoir (0.2M Lithium Sulfate, 0.1M CAPS, 1.2M NaH2PO4/0.8M K2HPO4), Cryoprotection (2M Li2SO4), VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 1.46 Å R-free 0.198 |
| 6KR4 Crystal structure of the liprin-alpha3_SAM123/LAR_D1D2 complex Deposited 2019-08-20 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
1332–1907(576 aa)
|
Not recorded | PG4 TETRAETHYLENE GLYCOL × 1 PO4 PHOSPHATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;296 K;50mM Tris-HCl, 200mM NaCl, 1mM ethylenediaminetetraacetic acid, 1mM dithiothreitol
|
Resolution 2.85 Å R-free 0.230 |
| 6KR4 Crystal structure of the liprin-alpha3_SAM123/LAR_D1D2 complex Deposited 2019-08-20 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
1332–1907(576 aa)
|
Not recorded | PG4 TETRAETHYLENE GLYCOL × 1 PO4 PHOSPHATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;296 K;50mM Tris-HCl, 200mM NaCl, 1mM ethylenediaminetetraacetic acid, 1mM dithiothreitol
|
Resolution 2.85 Å R-free 0.230 |
| 6KR4 Crystal structure of the liprin-alpha3_SAM123/LAR_D1D2 complex Deposited 2019-08-20 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain C
1332–1907(576 aa)
|
Not recorded | PG4 TETRAETHYLENE GLYCOL × 1 PO4 PHOSPHATE ION × 1 PGE TRIETHYLENE GLYCOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;296 K;50mM Tris-HCl, 200mM NaCl, 1mM ethylenediaminetetraacetic acid, 1mM dithiothreitol
|
Resolution 2.85 Å R-free 0.230 |
| 6KR4 Crystal structure of the liprin-alpha3_SAM123/LAR_D1D2 complex Deposited 2019-08-20 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain D
1332–1907(576 aa)
|
Not recorded | PO4 PHOSPHATE ION × 1 PGE TRIETHYLENE GLYCOL × 1 P6G HEXAETHYLENE GLYCOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;296 K;50mM Tris-HCl, 200mM NaCl, 1mM ethylenediaminetetraacetic acid, 1mM dithiothreitol
|
Resolution 2.85 Å R-free 0.230 |
| 6TPT Crystal structures of FNIII domain three and four of the human leucocyte common antigen-related protein, LAR Deposited 2019-12-14 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
512–706(195 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.5;277 K;0.2 M Sodium fluoride, 0.1 M Bis-tris propane pH 6.5, and 20% PEG3350
|
Resolution 3.20 Å R-free 0.269 |
| 6TPV Crystal structures of FNIII domain one and two of the human leucocyte common antigen-related protein, LAR Deposited 2019-12-14 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
319–512(194 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.3;277 K;0.2 M Sodium citrate tribasic dihydrate pH 8.3, 20 % PEG 3,350
|
Resolution 1.80 Å R-free 0.220 |
| 6TPV Crystal structures of FNIII domain one and two of the human leucocyte common antigen-related protein, LAR Deposited 2019-12-14 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
319–512(194 aa)
|
Not recorded | IMD IMIDAZOLE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.3;277 K;0.2 M Sodium citrate tribasic dihydrate pH 8.3, 20 % PEG 3,350
|
Resolution 1.80 Å R-free 0.220 |
| 6TPW Crystal structures of FNIII domain one through four of the human leucocyte common antigen-related protein ( LAR) Deposited 2019-12-14 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
319–706(388 aa)
|
Not recorded | SO4 SULFATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;277 K;0.2 M Ammonium sulfate and 30% PEG8000
|
Resolution 2.90 Å R-free 0.301 |
11 other PDB entries and 16 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | PTPRF_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 2–195; UniProt 513–706 Author chain B; PDBConstruct 2–195; UniProt 513–706 |